Steps in the management of psoriatic arthritis: a guide for clinicians.
Psoriatic arthritis is a common systemic inflammatory disorder, which in addition to skin and nail involvement may be associated with peripheral and axial joint involvement, enthesitis, dactylitis, and important comorbidities - especially cardiovascular morbidity. Better insights into the involved pathogenic mechanisms have resulted in an improved therapeutic armamentarium, which targets key pathways in its pathogenesis. This has resulted in significant clinical responses to newer therapeutic agents, especially those directed at inhibition of tumor necrosis factor α. Biological therapy leads to significant levels of remission, improved quality of life, and retards or improves structural radiological damage.
Department of Internal Medicine, Section of Rheumatology, LSU Health Sciences Center at New Orleans, New Orleans, LA, USA.
Raquel
R
Cuchacovich
Rodolfo
R
Perez-Alamino
Ignacio
I
Garcia-Valladares
Luis R
LR
Espinoza
T helper 17 cells; metabolic syndrome; psoriasis; psoriatic arthritis; rituximab; tumor necrosis factor α blockade